KRISTIN COLLADO: Open Payments
NPI 1295829364 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 89 payments from 31 companies in 2025. Trend: 2023 $64 · 2024 $39 · 2025 $1,756
Food & beverage: $1,558Education: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $219 |
| AstraZeneca Pharmaceuticals LP | 11 | $191 |
| Janssen Biotech, Inc. | 11 | $168 |
| PFIZER INC. | 6 | $120 |
| Merck Sharp & Dohme LLC | 5 | $101 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Astellas Pharma US Inc | 4 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
Products named: PADCEV, IMBRUVICA, FOTIVDA, RYBREVANT, Onivyde, ENHERTU, ADSTILADRIN, EPKINLY.
Industry payments across NY — which companies pay providers there.
